Count | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 4 | |
Ritonavir/*administration & dosage/adverse effects/*therapeutic use | 2 |
| 4 | |
| 1 | |
| 8 | |
| 1 | |
| 19 | |
| 12 | |
| 29 | |
| 2 | |
| 6 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 6 | |
| 1 | |
| 1 | |
Ritonavir/administration & dosage/pharmacokinetics/*standards | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 8 | |
| 3 | |
| 2 | |
| 7 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 3 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 3 | |
| 2 | |
| 5 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |